Moneycontrol PRO
you are here: HomeNewsBusiness

Buy Sanofi India; target of Rs 9750: ICICI Direct

ICICI Direct is bullish on Sanofi India has recommended buy rating on the stock with a target price of Rs 9750 in its research report dated July 28, 2021.

July 29, 2021 / 02:29 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

ICICI Direct's research report on Sanofi India


Sanofi offers drugs in therapies like diabetes (insulins & orals), cardiology, thrombosis, anti-infective, CNS, allergy, vitamins, minerals & supplements. Lantus, Allegra & Combiflam are in Top 100 pharmaceutical brands in India Sanofi is one of the fastest growing companies in India in anti-diabetic therapy


Outlook


We remain positive and retain our BUY rating on the stock We value Sanofi at Rs 9750 i.e. 35x P/E on FY23E EPS


For all recommendations report, click here

Close

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: Jul 29, 2021 02:29 pm
Sections
ISO 27001 - BSI Assurance Mark